Երկիր: Իռլանդիա
Լեզու: անգլերեն
Աղբյուրը: HPRA (Health Products Regulatory Authority)
CARBOCISTEINE
Pierre Fabre Medicament
R05CB03
CARBOCISTEINE
250/5 Mg/Ml
Oral Solution
Product not subject to medical prescription
carbocisteine
Not Marketed
2006-03-24
IE: PectoDrill sugar-free for chesty coughs 250mg/5ml oral solution. PA 329/009/002 Last approved: 04/2016 CRN 2173519 PACKAGE LEAFLET: INFORMATION FOR THE USER PECTODRILL SUGAR-FREE FOR CHESTY COUGHS 250MG/5 ML, ORAL SOLUTION Carbocisteine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 5 days WHAT IS IN THIS LEAFLET 1. What PectoDrill sugar-free is and what it is used for 2. What you need to know before you take PectoDrill sugar-free 3. How to take PectoDrill sugar-free 4. Possible side effects 5. How to store PectoDrill sugar-free 6. Contents of the pack and other information. 1. WHAT PECTODRILL SUGAR-FREE AND WHAT IT IS USED FOR PectoDrill sugar-free contains the active substance carbocisteine which belongs to a group of medicines known as mucolytics or expectorants. PectoDrill sugar-free is an oral solution for the treatment of chesty coughs. PectoDrill sugar-free is used for bronchial congestion associated with certain respiratory tract disorders. PectoDrill sugar-free is used to treat adults and children over 6 years of age. How PectoDrill sugar-free works PectoDrill sugar-free promotes coughing by thinning the secretions. It helps clear your bronchi of secretions causing congestion. You must talk to a doctor if you do not feel better or if you feel worse after 5 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PECTODRILL SUGAR-FREE DO NOT TAKE PECTODRILL SUGAR-FREE: - if you are allergic to carbocisteine or any of the other ingredients of this medicine (listed in section 6) - if you curre Կարդացեք ամբողջական փաստաթուղթը
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT PectoDrill sugar-free for chesty coughs 250mg/5ml oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Carbocisteine 5.00 g per 100 ml of oral solution Each 5ml contains 250mg carbocisteine Excipients with known effect: Each 5ml contains Methylparahydroxybenzoate (E218) 7.5mg Sodium 33.3mg Ethanol (alcohol) <100mg. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Oral solution Slightly brownish, clear solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Mucolytic agent for use in lower respiratory tract disorders characterised by excessive or viscous mucus. PectoDrill is indicated in adults and children over 6 years of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults and children 12 years and over: The usual dose is 15 ml three times daily initially, reducing to 10 ml three times daily when a satisfactory response has been obtained. The maximum daily dose for adults and children over 12 years of age is 45 ml. 15 ml of the syrup/oral solution contains 750 mg of carbocisteine. Children aged 6 to 12 years: One 5 ml (250 mg) measure three times daily. The maximum daily dose for children aged 6 to 12 years is 15 ml. Method of administration For oral use Treatment duration Duration of treatment must be restricted to five days after which time if symptoms continue, medical advice must be sought. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _5_ _/_ _0_ _5_ _/_ _2_ _0_ _ Կարդացեք ամբողջական փաստաթուղթը